Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Boots Dual Action Athlete's Foot Cream

Active Ingredient:
benzalkonium chloride, tolnaftate
Company:  
THE BOOTS COMPANY PLC See contact details
About Medicine
{healthcare_pro_orange} This information is for use by healthcare professionals
Last updated on emc: 04 Oct 2022
1. Name of the medicinal product

Boots Athlete's Foot Cream

2. Qualitative and quantitative composition

Active ingredient

Quantity

Tolnaftate BP

1.0%w/w

Benzalkonium chloride solution BP

0.2%v/w

Excipients of known effect

Quantity

Cetostearyl alcohol

6.0% w/w

See section 4.4 for further information.

For a full list of excipients, see Section 6.1

3. Pharmaceutical form

Cream

4. Clinical particulars
4.1 Therapeutic indications

Boots Dual Action Athlete's Foot Cream is indicated for the treatment and prevention of Athlete's Foot (Tinea Pedis). It is also effective in other conditions, such as Dhobie Itch (Tinea Cruris).

For cutaneous use.

4.2 Posology and method of administration

Adults, children and the elderly: The affected area should be treated morning and night. Treatment should continue for at least a week after the infection has cleared.

4.3 Contraindications

Hypersensitivity to any of the ingredients.

4.4 Special warnings and precautions for use

Keep all medicines out of the reach of children.

For external use only.

If symptoms persist consult your doctor.

Contains Cetostearyl alcohol which may cause local skin reactions (e.g. contact dermatitis)

4.5 Interaction with other medicinal products and other forms of interaction

No clinically significant drug interactions known.

4.6 Pregnancy and lactation

No special requirements.

4.7 Effects on ability to drive and use machines

No adverse effects known.

4.8 Undesirable effects

Occasionally may cause skin irritation, hypersensitivity and contact dermatitis.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard, or search Yellow Card in the Apple App or google Play Store.

4.9 Overdose

Not applicable.

5. Pharmacological properties
5.1 Pharmacodynamic properties

Tolnaftate is a well established drug substance having potent antifungal properties.

Benzalkonium chloride is a well established drug substance having potent anti-microbial properties.

5.2 Pharmacokinetic properties

Not applicable.

5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included.

6. Pharmaceutical particulars
6.1 List of excipients

Arlatone 983S

Cetostearyl alcohol

Dimethicone 20

Liquid paraffin

Glycerol

Purified water

6.2 Incompatibilities

Not applicable.

6.3 Shelf life

18 months

6.4 Special precautions for storage

Store in a cool place below 25°C.

6.5 Nature and contents of container

An internally lacquered metal tube with blind end nozzle. Tube to contain 25gm or 35gm.

6.6 Special precautions for disposal and other handling

None

7. Marketing authorisation holder

The Boots Company PLC

1 Thane Road West

Nottingham NG2 3AA

8. Marketing authorisation number(s)

PL0014/0457

9. Date of first authorisation/renewal of the authorisation

12 April 1994

10. Date of revision of the text

30th September 2022

THE BOOTS COMPANY PLC
Company image
Address
1 Thane Road West, Beeston, Nottingham, NG2 3AA
Telephone
+44 (0)1159 595 165
Fax
+44 (0)1159 592 565